RMD upped to Buy at First Albany; price tgt upped to $63/share
Tweet Send to a Friend
First Albany upgraded ResMed, Inc. (NYSE: RMD) from a 'neutral' to 'buy' rating and increased itsprice target 34.04% from $47 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
